UNSPSC 51432806: Enalapril maleate

This classification denotes an ace inhibitor with the molecular formula C20H28N2O5.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9O25354EPJ, chemically known as l-proline, n-((1s)-1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl- but more generally known as enalapril maleate, which bears US NIH Compound Identifier 5362032. European Medicines Agency schedules Enalapril maleate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01884MIG.

Most nations, for tariff and trade purposes, schedule enalapril maleate under HS 29339990 and SITC 51577. As of Q4 2014, ENALAPRIL MALEATE remains US FDA's Preferred Term for this commodity. Enalapril maleate bears US NLM identifiers UMLS ID C0600128 and NCI Concept Code C468. SMILES: CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51432806 Enalapril maleate is a Commodity code for a specific pharmaceutical product, but state and local governments soliciting under this code are actually procuring broad Advanced Life Support medication kits for emergency response. The City of Tampa's Purchasing Department is the only recent solicitation in the source data, issuing an IFB in April 2026 for Advanced Life Support Medications to supply Tampa Fire Rescue with four distinct medication line items—Labetalol, Epinephrine, Adenosine, and Diltiazem—in specified unit quantities. The work encompasses supply of pharmaceutical inventory with strict expiration and warranty requirements, logistics (pickup and replacement of expired stock before nine-month expiration), and regulatory compliance including Safety Data Sheets compliant with OSHA Hazard Communication Standards. The solicitation carries a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount, not to exceed $10,000, and vendors must demonstrate WCAG 2.2 Level AA and Section 508 accessibility conformance.

The source supports limited geographic visibility: activity is concentrated in Hillsborough County, Florida, where the City of Tampa issued the IFB (Bid No. 26-P-00188) with a response deadline of April 8, 2026 and an estimated contract value of $40,000. The contract term is one year from award with options to renew for two additional one-year periods and unilateral extension rights for up to three 30-day periods. Delivery is required within ten calendar days of order receipt, with electronic bids submitted through the OpenGov eProcurement Portal. Award is made to the lowest responsive, responsible bidder within 120 days of bid opening. The narrow recent-opportunity footprint and the mismatch between the Commodity code's specific pharmaceutical name and the broad medication-kit scope solicited suggest limited ongoing activity under this specific code designation.